1995
DOI: 10.1536/ihj.36.191
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of Early Development of Chronic Nonrheumatic Atrial Fibrillation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

1998
1998
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 27 publications
0
12
0
1
Order By: Relevance
“…In Japan, age, left atrial diameter, prior myocardial infarction, valvular heart disease, and diabetes mellitus have been reported as independent risk factors for the progression to persistent/permanent AF. 53, 54 In Western countries, the HATCH score (hypertension, age [75 years and older], transient ischemic attack or stroke, chronic obstructive pulmonary disease and heart failure) is used to predict the progression to permanent AF. 55 Patients with poor QOL due to paroxysmal AF should be treated with antiarrhythmic drugs to prevent episodes of AF.…”
Section: Paroxysmal Afmentioning
confidence: 99%
“…In Japan, age, left atrial diameter, prior myocardial infarction, valvular heart disease, and diabetes mellitus have been reported as independent risk factors for the progression to persistent/permanent AF. 53, 54 In Western countries, the HATCH score (hypertension, age [75 years and older], transient ischemic attack or stroke, chronic obstructive pulmonary disease and heart failure) is used to predict the progression to permanent AF. 55 Patients with poor QOL due to paroxysmal AF should be treated with antiarrhythmic drugs to prevent episodes of AF.…”
Section: Paroxysmal Afmentioning
confidence: 99%
“…Independent risk factors for progression to persistent AF appeared to be age, left atrial diameter, history of myocardial infarction, and valvular disease in a study using multivariate analysis, 65 and age, left atrial diameter, heart failure, diabetes mellitus, cardiothoracic ratio, f wave amplitude in lead V1, and left ventricular ejection fraction in a study using univariate analysis. 66 Patients with poor QOL due to paroxysmal AF should be treated with antiarrhythmic drugs to prevent episodes of AF. However, the duration of pharmacotherapy needed to maintain sinus rhythm should be determined for individual patients based on comprehensive evaluation of the duration of treatment, background characteristics, and feasibility of non-pharmacological treatment with catheter ablation.…”
Section: Paroxysmal Afmentioning
confidence: 99%
“…4) Factors related to the development of permanent AF have been reported. 2,[5][6][7] A number of recent studies 3,[8][9][10][11] have associated AF and its treatment with quality-of-life issues.…”
Section: Discussionmentioning
confidence: 99%